Medicare Enrolled

Dr. Marque Hunter, M.D.

Pulmonary Disease · Lubbock, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3621 22ND ST., Lubbock, TX 79410
8067918484
In practice since 2006 (19 years)
NPI: 1568485258 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hunter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hunter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hunter

Dr. Marque Hunter is a pulmonary disease in Lubbock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Hunter performed 2,234 Medicare services across 1,304 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hunter received a total of $13,573 from 42 pharmaceutical and/or device companies across 765 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hunter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 15% volume in TX$ $13,573 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,234
Medicare services
Top 15% in TX for pulmonary disease
1,304
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~118 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity558$90$164
Hospital follow-up visit, moderate complexity442$60$115
Critical care, first 30-74 min242$162$510
Office visit, established patient (30-39 min)145$65$172
Test to examine how well the lungs exchange gases138$6$28
Test to determine lung volumes using gas dilution or washout134$9$39
Office visit, established patient (20-29 min)129$41$111
Test to measure expiratory airflow and volume117$6$26
Chest X-ray, 1 view96$6$67
Initial hospital admission, moderate complexity51$96$405
Test to measure expiratory airflow and volume changes before and after medication administration40$8$47
Sleep study in sleep lab with continuous airway pressure (6 years or older)37$92$585
Sleep study in sleep lab (6 years or older)29$90$542
New patient office visit (45-59 min)28$92$285
New patient office visit (30-44 min)19$50$202
CT scan of chest, without contrast16$66$336
Low dose ct scan of chest for lung cancer screening13$86$325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,573
Total received (2018-2024)
Avg $1,939/year across 7 years
Top 15% in TX for pulmonary disease
42
Companies
765
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,557 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,606
2023
$2,650
2022
$2,624
2021
$1,922
2020
$1,229
2019
$1,238
2018
$1,304

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$3,483
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,670
AstraZeneca Pharmaceuticals LP
$1,371
Grifols USA, LLC
$1,055
Amgen Inc.
$632
Mylan Specialty L.P.
$618
Baxter Healthcare
$456
Actelion Pharmaceuticals US, Inc.
$445
GENZYME CORPORATION
$413
Janssen Pharmaceuticals, Inc
$390
Regeneron Healthcare Solutions, Inc.
$383
Takeda Pharmaceuticals U.S.A., Inc.
$295
Sunovion Pharmaceuticals Inc.
$252
Harmony Biosciences LLC
$191
ABIOMED
$188
United Therapeutics Corporation
$161
Inspire Medical Systems, Inc.
$158
PFIZER INC.
$137
Genentech USA, Inc.
$126
Philips Electronics North America Corporation
$96
Merck Sharp & Dohme Corporation
$92
Nabriva Therapeutics, plc
$88
AbbVie Inc.
$88
Gilead Sciences, Inc.
$82
Mallinckrodt Hospital Products Inc.
$76
Medivance, Inc.
$75
Merck Sharp & Dohme LLC
$71
Insmed, Inc.
$70
Electromed, Inc.
$64
Shire North American Group Inc
$51
Advanced Respiratory, Inc
$45
Bayer HealthCare Pharmaceuticals Inc.
$40
Inari Medical, Inc.
$40
PORTOLA PHARMACEUTICALS, INC.
$36
Allergan Inc.
$28
UCB, Inc.
$23
Boston Scientific Corporation
$18
ABBVIE INC.
$14
ANI Pharmaceuticals, Inc.
$14
INOGEN, INC.
$14
SANOFI-AVENTIS U.S. LLC
$14
Inogen, Inc.
$12
Top 3 companies account for 48.1% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BMD Medivance · BREO · BREZTRI · BREZTRI AEROSPHERE · Briviact · DUPIXENT · EXALT Model D · Esbriet · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · Impella · InogenOne · Inspire Upper Airway Stimulation System · KEYTRUDA · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · OFEV · OFIRMEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PULMICORT RESPULES · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · S · SEEBRI · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TAVNEOS · TERLIVAZ · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · VPRIV · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · XIGDUO · Xenleta · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $608 per 100 Medicare services performed
Looking for a pulmonary disease in Lubbock?
Compare pulmonary diseases in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
11
Per 100K population
3.5
County median income
$63,367
Nearest hospital
COVENANT MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hunter is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), and high industry engagement (low-engagement, top 15%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hunter experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Hunter performed 558 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hunter receive payments from pharmaceutical companies?
Yes. Dr. Hunter received a total of $13,573 from 42 companies across 765 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hunter's costs compare to other pulmonary diseases in Lubbock?
Dr. Hunter's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hunter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →